BC
AST.WS

Broadwood Capital’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Broadwood Capital’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-328,205
Closed -$164K – 8
2017
Q2 		$164K Hold
328,205
– – 0.03% 8
2017
Q1 		$140K Hold
328,205
– – 0.03% 8
2016
Q4 		$179K Hold
328,205
– – 0.03% 9
2016
Q3 		$171K Hold
328,205
– – 0.03% 9
2016
Q2 		$70K Buy
+328,205
New +$171K 0.01% 10

Broadwood Capital's AST.WS Position: Q3 2017 in Review

Broadwood Capital sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 328,205 shares — an estimated $164K sold.

Broadwood Capital first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $179K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Broadwood Capital reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Broadwood Capital sold 328,205 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $164K.
  • Broadwood Capital first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Broadwood Capital's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $179K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Broadwood Capital's 13F filing for Q3 2017, filed 14 Nov 2017.